How bacteria build and sense their protective cell wall using lab-made mimics
Unraveling Bacterial Cell Wall Biosynthesis and Sensing via Synthetic Analogs
Researchers are making tagged, fake pieces of bacterial cell wall so they can watch how bacteria build and repair their walls, with the goal of helping people facing antibiotic-resistant infections.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Virginia NIH-funded |
| Lab location | 1 site (Charlottesville, United States) |
| Project ID | NIH-11180433 on NIH RePORTER |
What this research studies
This project makes synthetic versions of bacterial cell-wall components that bacteria will process during growth, and the team adds chemical tags so those pieces can be tracked. In the lab they use these tagged probes with biochemical assays and imaging to see which enzymes and pathways handle cell-wall assembly and sensing. The investigators focus especially on peptidoglycan, a key cell-wall component targeted by many antibiotics, and will develop assays to reveal weak points in bacterial defenses. Insights from these experiments aim to point to new molecular targets or strategies to overcome drug-resistant bacteria.
Who could benefit from this research
Good fit: People who have or are at high risk for antibiotic-resistant bacterial infections would be the eventual beneficiaries and could be candidates for later clinical studies based on these findings.
Not a fit: Patients with non-bacterial conditions or infections already well controlled by existing antibiotics are unlikely to see direct benefits from this lab-focused research.
Why it matters
Potential benefit: If successful, the work could identify new targets and tests that lead to antibiotics or treatments effective against drug-resistant bacterial infections.
How similar studies have performed: Related chemical-probe approaches have successfully mapped bacterial cell-wall processes in the lab and have informed antibiotic discovery, though moving lab findings into new treatments remains difficult.
Where this research is happening
Charlottesville, United States
- University of Virginia — Charlottesville, United States (Active)
Researchers
- Principal investigator: Pires, Marcos M. — University of Virginia
- Study coordinator: Pires, Marcos M.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.